|
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2018 |
Oct 16 2018 |
47 |
Global |
$3,500.00 |
|
|
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018 |
Oct 16 2018 |
84 |
Global |
$2,000.00 |
|
|
Pompe Disease - Pipeline Review, H2 2018 |
Oct 16 2018 |
82 |
Global |
$2,000.00 |
|
|
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 |
Oct 16 2018 |
73 |
Global |
$3,500.00 |
|
|
Chikungunya Fever - Pipeline Review, H2 2018 |
Oct 16 2018 |
104 |
Global |
$2,000.00 |
|
|
Optic Neuritis - Pipeline Review, H2 2018 |
Oct 16 2018 |
45 |
Global |
$2,000.00 |
|
|
Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Pipeline Review, H2 2018 |
Oct 16 2018 |
54 |
Global |
$3,500.00 |
|
|
Japanese Encephalitis - Pipeline Review, H2 2018 |
Oct 16 2018 |
48 |
Global |
$2,000.00 |
|
|
Overactive Bladder - Pipeline Review, H2 2018 |
Oct 16 2018 |
109 |
Global |
$2,000.00 |
|
|
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018 |
Oct 16 2018 |
80 |
Global |
$3,500.00 |
|
|
Rotavirus Infections - Pipeline Review, H2 2018 |
Oct 16 2018 |
51 |
Global |
$2,000.00 |
|
|
Sickle Cell Disease - Pipeline Review, H2 2018 |
Oct 16 2018 |
219 |
Global |
$2,000.00 |
|
|
C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2018 |
Oct 16 2018 |
50 |
Global |
$3,500.00 |
|
|
Yellow Fever - Pipeline Review, H2 2018 |
Oct 16 2018 |
52 |
Global |
$2,000.00 |
|
|
Kidney Fibrosis - Pipeline Review, H2 2018 |
Oct 16 2018 |
156 |
Global |
$2,000.00 |
|
|
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2018 |
Oct 16 2018 |
55 |
Global |
$3,500.00 |
|
|
Pheochromocytoma - Pipeline Review, H2 2018 |
Oct 16 2018 |
94 |
Global |
$2,000.00 |
|
|
Acne Vulgaris - Pipeline Review, H2 2018 |
Oct 16 2018 |
186 |
Global |
$2,000.00 |
|
|
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2018 |
Oct 16 2018 |
29 |
Global |
$3,500.00 |
|
|
Post Menopausal Osteoporosis - Pipeline Review, H2 2018 |
Oct 16 2018 |
92 |
Global |
$2,000.00 |
|
|
Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2018 |
Oct 16 2018 |
171 |
Global |
$3,500.00 |
|
|
Essential Thrombocythemia - Pipeline Review, H2 2018 |
Oct 16 2018 |
94 |
Global |
$2,000.00 |
|
|
Heavy Metal Poisoning - Pipeline Review, H2 2018 |
Oct 16 2018 |
40 |
Global |
$2,000.00 |
|
|
Hairy Cell Leukemia - Pipeline Review, H2 2018 |
Oct 16 2018 |
97 |
Global |
$2,000.00 |
|
|
Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2018 |
Oct 16 2018 |
62 |
Global |
$3,500.00 |
|
|
P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2018 |
Oct 16 2018 |
48 |
Global |
$3,500.00 |
|
|
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018 |
Oct 16 2018 |
218 |
Global |
$2,000.00 |
|
|
Polycystic Kidney Disease - Pipeline Review, H2 2018 |
Oct 16 2018 |
100 |
Global |
$2,000.00 |
|
|
Ureter Cancer - Pipeline Review, H2 2018 |
Oct 16 2018 |
206 |
Global |
$2,000.00 |
|
|
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2018 |
Oct 16 2018 |
64 |
Global |
$3,500.00 |
|
